Immunotoxin Global Market Report 2025

Description

Immunotoxins are bioengineered proteins that combine an antibody or antibody fragment with a toxin to specifically target and destroy certain cells, such as cancer cells. The antibody segment of the immunotoxin attaches to a specific antigen on the surface of the target cell, delivering the toxin directly to it. Immunotoxins are crafted to avoid harming healthy cells and tissues, thereby reducing side effects compared to traditional chemotherapy.

The primary types of immunotoxins include anthrax-based toxins, diphtheria toxin (DT) and its derivatives, pseudomonas exotoxin (PE) and its derivatives, ribosome-inactivating protein-based immunotoxins, ribonuclease-based immunotoxins, among others. Anthrax-based toxins are substances produced by the bacteria that cause anthrax, a severe disease. These toxins are used in various applications, including the treatment of solid tumors, leukemias, and more, by different end users such as hospitals and clinics, cancer and radiation therapy centers, research laboratories, and others.

The immunotoxins market research report is one of a series of new reports from The Business Research Company that provides immunotoxins market statistics, including the immunotoxins industry global market size, regional shares, competitors with immunotoxins market share, detailed immunotoxins market segments, market trends, and opportunities, and any further data you may need to thrive in the immunotoxins industry. These immunotoxins market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The immunotoxin market size has grown strongly in recent years. It will grow from $60.97 billion in 2024 to $66.62 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to the discovery of target antigens, advancements in monoclonal antibody technology, preclinical efficacy studies, clinical trials and regulatory approval, and identification of resistance mechanisms.

The immunotoxin market size is expected to see strong growth in the next few years. It will grow to $93.93 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the increasing incidence of cancer, rising demand for natural and organic products, expansion of the cosmetic industry, expansion of R and D financing, and improving healthcare infrastructure. Major trends in the forecast period include precision medicine approach, enhanced targeting strategies, multifunctional immunotoxins, combination therapies, and advancements in monoclonal antibody technology.

The rising incidence of breast cancer is anticipated to drive the growth of the immunotoxin market. Breast cancer, a type of cancer that develops in breast cells, is becoming more common due to factors such as improved screening, lifestyle changes, and increased life expectancy. Immunotoxins assist in breast cancer treatment by specifically targeting and killing cancer cells while sparing healthy cells, thereby reducing the side effects commonly associated with traditional chemotherapy. For example, according to the American Cancer Society, a US-based non-profit organization, there were 300,590 new cases of breast cancer reported in 2023, an increase from the 290,560 cases reported in 2022. Thus, the rising incidence of breast cancer is fueling the expansion of the immunotoxin market.

Leading companies in the immunotoxin market are concentrating on developing antibody-drug conjugates (ADCs) to improve the precision and effectiveness of cancer treatments. ADCs are biopharmaceuticals designed for targeted cancer therapy, consisting of an antibody linked to a cytotoxic drug, which allows for the targeted delivery of the drug to cancer cells expressing a specific antigen. For instance, in April 2024, Pfizer Inc., a US-based pharmaceutical company, and Genmab A/S, a Denmark-based biotechnology company, received full U.S. Food and Drug Administration (FDA) approval for TIVDAK, an antibody-drug conjugate designed to treat patients with metastatic or recurrent cervical cancer. TIVDAK's toxic payload, monomethyl auristatin E, is a microtubule-disrupting agent that induces cell death. This novel mechanism contributes to its effectiveness in cancer treatment. TIVDAK demonstrated statistically significant improvements in overall survival, making it a promising option for patients with recurrent or metastatic cervical cancer.

In February 2024, AbbVie, a US-based biopharmaceutical company, acquired ImmunoGen, Inc. for an undisclosed amount. Through this acquisition, AbbVie seeks to strengthen its oncology portfolio by incorporating ImmunoGen's cutting-edge antibody-drug conjugate technology, thus advancing the development of targeted cancer therapies. ImmunoGen, Inc. is a biotechnology company specializing in immunotoxins.

Major companies operating in the immunotoxin market are Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Bristol Myers Squibb, Thermo Fisher Scientific Inc., AstraZeneca plc, Merck KGaA, BioNTech SE, Ipsen Pharma, Seagen Inc., Orion Corporation, GenScript, Cytek Biosciences, MacroGenics Inc., Sutro Biopharma Inc., Sorrento Therapeutics Inc., Innate Pharma Inc., Cayman Chemical, ImmunoGen Inc., Mersana Therapeutics, Molecular Templates Inc., Celldex Therapeutics, CytImmune Sciences Inc., Enzo Life Sciences Inc.

North America was the largest region in the immunotoxin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunotoxin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the immunotoxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunotoxin market consists of sales of linker molecules, expression systems, antibody or antibody fragments, and cytotoxic agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunotoxin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunotoxin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunotoxin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The immunotoxin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Anthrax Based Toxins; Diphtheria Toxin (DT) And Derivatives; Pseudomonas Exotoxin (PE) And Derivatives; Ribosome Inactivating Proteins Based Immunotoxins; Ribonucleases-Based Immunotoxins; Other Types
2) By Application: Solid Tumors; Leukemias; Other Applications
3) By End User: Hospitals And Clinics; Cancer And Radiation Therapy Centers; Research Labs; Other End-Users
Subsegments:
1) By Anthrax-Based Toxins: Anthrax Lethal Toxin; Anthrax Protective Antigen
2) By Diphtheria Toxin (DT) And Derivatives: Diphtheria Toxin; DT Fragment-Based Immunotoxins
3) By Pseudomonas Exotoxin (PE) And Derivatives: PE38-Based Immunotoxins; PE-Based Fusion Proteins
4) By Ribosome Inactivating Proteins-Based Immunotoxins: Ricin-Based Immunotoxins; Gelonin-Based Immunotoxins
5) By Ribonucleases-Based Immunotoxins: Onconase-Based Immunotoxins; Binase-Based Immunotoxins
6) By Other Types: Shiga Toxin-Based Immunotoxins; Other Toxin-Based Immunotoxins
Companies Mentioned: Pfizer Inc.; Roche Holding AG; AbbVie Inc.; Bayer AG; Bristol Myers Squibb
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r30447

1. Executive Summary

2. Immunotoxin Market Characteristics

3. Immunotoxin Market Trends And Strategies

4. Immunotoxin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Immunotoxin Growth Analysis And Strategic Analysis Framework

5.1. Global Immunotoxin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Immunotoxin Market Growth Rate Analysis
5.4. Global Immunotoxin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Immunotoxin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Immunotoxin Total Addressable Market (TAM)

6. Immunotoxin Market Segmentation

6.1. Global Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anthrax Based Toxins
Diphtheria Toxin (DT) And Derivatives
Pseudomonas Exotoxin (PE) And Derivatives
Ribosome Inactivating Proteins Based Immunotoxins
Ribonucleases-Based Immunotoxins
Other Types
6.2. Global Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Solid Tumors
Leukemias
Other Applications
6.3. Global Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Cancer And Radiation Therapy Centers
Research Labs
Other End-Users
6.4. Global Immunotoxin Market, Sub-Segmentation Of Anthrax-Based Toxins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anthrax Lethal Toxin
Anthrax Protective Antigen
6.5. Global Immunotoxin Market, Sub-Segmentation Of Diphtheria Toxin (DT) And Derivatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diphtheria Toxin
DT Fragment-Based Immunotoxins
6.6. Global Immunotoxin Market, Sub-Segmentation Of Pseudomonas Exotoxin (PE) And Derivatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PE38-Based Immunotoxins
PE-Based Fusion Proteins
6.7. Global Immunotoxin Market, Sub-Segmentation Of Ribosome Inactivating Proteins-Based Immunotoxins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ricin-Based Immunotoxins
Gelonin-Based Immunotoxins
6.8. Global Immunotoxin Market, Sub-Segmentation Of Ribonucleases-Based Immunotoxins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Onconase-Based Immunotoxins
Binase-Based Immunotoxins
6.9. Global Immunotoxin Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Shiga Toxin-Based Immunotoxins
Other Toxin-Based Immunotoxins

7. Immunotoxin Market Regional And Country Analysis

7.1. Global Immunotoxin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Immunotoxin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunotoxin Market

8.1. Asia-Pacific Immunotoxin Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunotoxin Market

9.1. China Immunotoxin Market Overview
9.2. China Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunotoxin Market

10.1. India Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunotoxin Market

11.1. Japan Immunotoxin Market Overview
11.2. Japan Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunotoxin Market

12.1. Australia Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunotoxin Market

13.1. Indonesia Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunotoxin Market

14.1. South Korea Immunotoxin Market Overview
14.2. South Korea Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunotoxin Market

15.1. Western Europe Immunotoxin Market Overview
15.2. Western Europe Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunotoxin Market

16.1. UK Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunotoxin Market

17.1. Germany Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunotoxin Market

18.1. France Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunotoxin Market

19.1. Italy Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunotoxin Market

20.1. Spain Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunotoxin Market

21.1. Eastern Europe Immunotoxin Market Overview
21.2. Eastern Europe Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunotoxin Market

22.1. Russia Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunotoxin Market

23.1. North America Immunotoxin Market Overview
23.2. North America Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunotoxin Market

24.1. USA Immunotoxin Market Overview
24.2. USA Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunotoxin Market

25.1. Canada Immunotoxin Market Overview
25.2. Canada Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunotoxin Market

26.1. South America Immunotoxin Market Overview
26.2. South America Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunotoxin Market

27.1. Brazil Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunotoxin Market

28.1. Middle East Immunotoxin Market Overview
28.2. Middle East Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunotoxin Market

29.1. Africa Immunotoxin Market Overview
29.2. Africa Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunotoxin Market Competitive Landscape And Company Profiles

30.1. Immunotoxin Market Competitive Landscape
30.2. Immunotoxin Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

31. Immunotoxin Market Other Major And Innovative Companies

31.1. Thermo Fisher Scientific Inc.
31.2. AstraZeneca plc
31.3. Merck KGaA
31.4. BioNTech SE
31.5. Ipsen Pharma
31.6. Seagen Inc.
31.7. Orion Corporation
31.8. GenScript
31.9. Cytek Biosciences
31.10. MacroGenics Inc.
31.11. Sutro Biopharma Inc.
31.12. Sorrento Therapeutics Inc.
31.13. Innate Pharma Inc.
31.14. Cayman Chemical
31.15. ImmunoGen Inc.

32. Global Immunotoxin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunotoxin Market

34. Recent Developments In The Immunotoxin Market

35. Immunotoxin Market High Potential Countries, Segments and Strategies

35.1 Immunotoxin Market In 2029 - Countries Offering Most New Opportunities
35.2 Immunotoxin Market In 2029 - Segments Offering Most New Opportunities
35.3 Immunotoxin Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer